280 related articles for article (PubMed ID: 15896460)
1. Cyclin D1 G870A polymorphism and squamous cell carcinoma of the uterine cervix in Korean women.
Jeon YT; Kim JW; Song JH; Park NH; Song YS; Kang SB; Lee HP
Cancer Lett; 2005 Jun; 223(2):259-63. PubMed ID: 15896460
[TBL] [Abstract][Full Text] [Related]
2. Genetic variant of CCND1: association with HPV-mediated cervical cancer in Indian population.
Thakur N; Hussain S; Kohaar I; Tabassum R; Nasare V; Tiwari P; Batra S; Bhambhani S; Das BC; Basir SF; Bharadwaj D; Bharadwaj M
Biomarkers; 2009 Jun; 14(4):219-25. PubMed ID: 19489683
[TBL] [Abstract][Full Text] [Related]
3. Association of cyclin D1 polymorphism with increased susceptibility to oral squamous cell carcinoma.
Holley SL; Matthias C; Jahnke V; Fryer AA; Strange RC; Hoban PR
Oral Oncol; 2005 Feb; 41(2):156-60. PubMed ID: 15695117
[TBL] [Abstract][Full Text] [Related]
4. Increased risk of cervical cancer associated with cyclin D1 gene A870G polymorphism.
Catarino R; Matos A; Pinto D; Pereira D; Craveiro R; Vasconcelos A; Lopes C; Medeiros R
Cancer Genet Cytogenet; 2005 Jul; 160(1):49-54. PubMed ID: 15949570
[TBL] [Abstract][Full Text] [Related]
5. Polymorphism within the cyclin D1 gene is associated with prognosis in patients with squamous cell carcinoma of the head and neck.
Matthias C; Branigan K; Jahnke V; Leder K; Haas J; Heighway J; Jones PW; Strange RC; Fryer AA; Hoban PR
Clin Cancer Res; 1998 Oct; 4(10):2411-8. PubMed ID: 9796972
[TBL] [Abstract][Full Text] [Related]
6. Role of BCL2 (ala43thr), CCND1 (G870A) and FAS (A-670G) polymorphisms in modulating the risk of developing esophageal cancer.
Jain M; Kumar S; Lal P; Tiwari A; Ghoshal UC; Mittal B
Cancer Detect Prev; 2007; 31(3):225-32. PubMed ID: 17561354
[TBL] [Abstract][Full Text] [Related]
7. Association of cyclin D1 G870A polymorphism with susceptibility to gastric cancers in Korean male patients.
Song JH; Kim CJ; Cho YG; Park YK; Nam SW; Yoo NJ; Lee JY; Park WS
Neoplasma; 2007; 54(3):235-9. PubMed ID: 17447856
[TBL] [Abstract][Full Text] [Related]
8. CCND1 rs9344 polymorphisms are associated with the genetic susceptibility to cervical cancer in Chinese population.
Wang N; Qian X; Wang S; Gao H; Wang L; Huo Y; Zhang S
Mol Carcinog; 2012 Feb; 51(2):196-205. PubMed ID: 21594903
[TBL] [Abstract][Full Text] [Related]
9. Cyclin D1 polymorphism and the risk of endometrial cancer.
Kang S; Kim JW; Park NH; Song YS; Kang SB; Lee HP
Gynecol Oncol; 2005 May; 97(2):431-5. PubMed ID: 15863141
[TBL] [Abstract][Full Text] [Related]
10. Cyclin D1 (CCND1) A870G gene polymorphism modulates smoking-induced lung cancer risk and response to platinum-based chemotherapy in non-small cell lung cancer (NSCLC) patients.
Gautschi O; Hugli B; Ziegler A; Bigosch C; Bowers NL; Ratschiller D; Jermann M; Stahel RA; Heighway J; Betticher DC
Lung Cancer; 2006 Mar; 51(3):303-11. PubMed ID: 16406195
[TBL] [Abstract][Full Text] [Related]
11. The influence of cyclin D1 A870G polymorphism on colorectal cancer risk and prognosis in a Turkish population.
Yaylim-Eraltan I; Arikan S; Yildiz Y; Cacina C; Ergen HA; Tuna G; Görmüs U; Zeybek U; Isbir T
Anticancer Res; 2010 Jul; 30(7):2875-80. PubMed ID: 20683026
[TBL] [Abstract][Full Text] [Related]
12. CCND1 polymorphisms (A870G and C1722G) modulate its protein expression and survival in oral carcinoma.
Sathyan KM; Nalinakumari KR; Abraham T; Kannan S
Oral Oncol; 2008 Jul; 44(7):689-97. PubMed ID: 18061526
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer and cyclin D1 gene polymorphism in Turkish women.
Yaylim-Eraltan I; Ergen A; Görmüs U; Arikan S; Küçücük S; Sahin O; Yigit N; Yildiz Y; Isbir T
In Vivo; 2009; 23(5):767-72. PubMed ID: 19779113
[TBL] [Abstract][Full Text] [Related]
14. Tumor susceptibility and prognosis of breast cancer associated with the G870A polymorphism of CCND1.
Yu CP; Yu JC; Sun CA; Tzao C; Ho JY; Yen AM
Breast Cancer Res Treat; 2008 Jan; 107(1):95-102. PubMed ID: 18043898
[TBL] [Abstract][Full Text] [Related]
15. Lack of association between CCND1 G870A polymorphism and the risk of breast and colorectal cancers.
Grieu F; Malaney S; Ward R; Joseph D; Iacopetta B
Anticancer Res; 2003; 23(5b):4257-9. PubMed ID: 14666635
[TBL] [Abstract][Full Text] [Related]
16. Association of cyclin D1 gene polymorphisms with risk of esophageal squamous cell carcinoma in Kashmir Valley: a high risk area.
Hussain S; M Y; Thakur N; Salam I; Singh N; Mir MM; Bhat MA; Siddiqi MA; Das BC; Bharadwaj M
Mol Carcinog; 2011 Jul; 50(7):487-98. PubMed ID: 21268129
[TBL] [Abstract][Full Text] [Related]
17. Cyclin D1 A870G polymorphism and amplification in laryngeal squamous cell carcinoma: implications of tumor localization and tobacco exposure.
Monteiro E; Varzim G; Pires AM; Teixeira M; Lopes C
Cancer Detect Prev; 2004; 28(4):237-43. PubMed ID: 15350626
[TBL] [Abstract][Full Text] [Related]
18. Cyclin D1 gene polymorphism and susceptibility to lung cancer in a Chinese population.
Qiuling S; Yuxin Z; Suhua Z; Cheng X; Shuguang L; Fengsheng H
Carcinogenesis; 2003 Sep; 24(9):1499-503. PubMed ID: 12807740
[TBL] [Abstract][Full Text] [Related]
19. Lack of association between CCND1 G870A polymorphism and risk of esophageal squamous cell carcinoma.
Yu C; Lu W; Tan W; Xing D; Liang G; Miao X; Lin D
Cancer Epidemiol Biomarkers Prev; 2003 Feb; 12(2):176. PubMed ID: 12582032
[No Abstract] [Full Text] [Related]
20. Association of polymorphisms in the cyclin D1 and XPD genes and susceptibility to cancers of the upper aero-digestive tract.
Buch S; Zhu B; Davis AG; Odom D; Siegfried JM; Grandis JR; Romkes M
Mol Carcinog; 2005 Apr; 42(4):222-8. PubMed ID: 15754315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
